Editorial

What place for the new biologics in the treatment of necrotising vasculitides

D. Jayne

Nephrology and Vasculitis, Renal Unit, Addenbrooke’s Hospital, Cambridge, UK.

Key words

Biologic agents, vasculitis, ANCA, Rituximab, anti-TNFa, vasculitis treatment.

Please address correspondence to: David Jayne, MD, FRCP,

Consultant in Nephrology and Vasculitis, Box 118, Renal Unit, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK.

E-mail: dj106@cam.ac.uk

Clin Exp Rheumatol 2006; 24 (Suppl.41): S1-S5.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2006.